U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07281898) titled 'Burst Stimulation for Paroxysmal Atrial Fibrillation' on Nov. 23.
Brief Summary: Atrial fibrillation (AF) is one of the most common cardiac arrhythmias worldwide, associated with high morbidity and mortality rates. Epidemiological studies in China show that the prevalence of AF in individuals aged >=60 years ranges from 2% to 3%, with rates continuing to rise due to population aging. Paroxysmal atrial fibrillation (PAF), if inadequately controlled, tends to progress to persistent AF, significantly increasing the risk of stroke, heart failure, and death. Catheter ablation has become a first-line therapy for drug-refractory PAF, with ...